Bart Filius
Director/Board Member chez PROQR THERAPEUTICS N.V.
Fortune : - $ au 29/02/2024
Profil
Actuellement, Bart Filius est président et directeur de l'exploitation de Galapagos NV. M. Filius siège également au conseil d'administration de Galapagos Biotech Ltd. et de ProQR Therapeutics NV. Au cours de sa carrière, M. Filius a occupé les postes de directeur financier et de directeur national chez Sanofi-Aventis Netherlands BV et de directeur financier de Sanofi European Treasury Center SA. M. Filius a obtenu un diplôme de premier cycle à la Nyenrode Business Universiteit et un MBA à l'INSEAD.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
PROQR THERAPEUTICS N.V.
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Postes actifs de Bart Filius
Sociétés | Poste | Début |
---|---|---|
PROQR THERAPEUTICS N.V. | Director/Board Member | 21/05/2019 |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Anciens postes connus de Bart Filius
Sociétés | Poste | Fin |
---|---|---|
GALAPAGOS NV | President | 30/06/2023 |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Part of Sanofi, Sanofi European Treasury Center SA provides financial services. The private company is based in Brussels, Belgium. | Director of Finance/CFO | 01/12/2014 |
sanofi-aventis Netherlands BV | Director of Finance/CFO | 01/03/2012 |
Formation de Bart Filius
Nyenrode Business Universiteit | Undergraduate Degree |
INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GALAPAGOS NV | Health Technology |
PROQR THERAPEUTICS N.V. | Health Technology |
Entreprise privées | 3 |
---|---|
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
sanofi-aventis Netherlands BV | |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Part of Sanofi, Sanofi European Treasury Center SA provides financial services. The private company is based in Brussels, Belgium. | Finance |